ASCO Partners with Societies Worldwide at 2009 Annual Meeting

ASCO SIGN IN

Manage Email Subscriptions

Username:

Create an account

Why Be A Member?

Password:

Remember me

Forgot your username or password?

ASCO Membership Directory

The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

ASCO Home

Press Center

ASCO Partners with Societies Worldwide at 2009 Annual Meeting

Contact: Danielle Potuto
danielle.potuto@asco.org
571-483-1375

Alexandria, VA – In an effort to foster the exchange of knowledge and resources to advance progress against cancer worldwide, ASCO has partnered with several organizations to hold joint education sessions at its 2009 Annual Meeting in Orlando, May 29 – June 2. Topics to be discussed include: imaging response; personalized cancer care; key research in hematologic malignancies; challenges and solutions in global clinical trials; and molecular imaging and cancer therapy.

“We are pleased to partner with these outstanding organizations to bring relevant scientific research to oncologists and other health care professionals via the ASCO Annual Meeting,” said ASCO President Richard L. Schilsky, MD. “Together, we are paving the way to improve strategies for prevention, early diagnosis, treatment and care for people with cancer.”

ASCO and the Radiological Society of North America (RSNA) will hold a joint session titled Is This Treatment Helping? Imaging Response in 2009. The Response Evaluation Criteria in Solid Tumors (RECIST), introduced in 2000, established unifying criteria to evaluate the change in tumor burden in response to therapy. These criteria have now been revised to accommodate relevant issues and to reduce the time required to analyze clinical data. This session will address what these changes are and how they can improve outcome measures in clinical studies. This session will be held on Sunday, May 31 from 8:00 AM -- 9:15 AM in room W415A (Valencia Room).

ASCO and the American Association of Cancer Research (AACR) have planned a joint session called Personalized Cancer Therapy—Pathways to Progress. The session will focus on the development of targeted therapies for cancer prevention and treatment, and the close collaboration and combined resources of basic scientists and clinical investigators. This session will be held on Sunday, May 31 from 9:30 to 10:45 AM in room West Hall D1, Level 2.

ASCO and the American Society of Hematology (ASH) have planned a joint session called The Best of ASH. The session will provide an in-depth review of some of the best science and top presentations from the recent ASH Annual Meeting. Topics include treatment advances in leukemia and lymphoma, combating blood clots, therapeutic strategies for platelet disorders, and improvements in stem cell therapies. This session will be held on Monday, June 1 from 8:00 to 9:15 AM in West Hall F5, Level 2.

ASCO and the Radiological Society of North America (RSNA) have planned a joint session called Optimize Your Patient’s Care: Talk to Your Radiologist. The increasing availability of sophisticated imaging tools and procedures, the major advances made in the understanding of cancer biology, and the advent of novel therapies have added complexity to the management of patients with cancer with regard to the choice of the proper imaging modality, and the interpretation of the imaging test. This session will offer a unique opportunity to discuss these issues in an interdisciplinary format and identify ways of using imaging technologies in optimizing patient care. This session will be held on Monday, June 1 from 11:30 AM to 12:45 PM in room W415D (Valencia Room).

ASCO and the European Society for Medical Oncology (ESMO) will hold a joint session called Global Clinical Trials—Challenges and Solutions. The globalization of cancer clinical research provides great opportunity as well as daunting challenges and this session will hone in on some of these obstacles and explore potential solutions. Specific topics include patient accrual, biospecimen acquisition, and clinical trial design. This session will be held from 3:00 – 4:15 PM in West Hall F5, Level 2.

ASCO and the Society for Nuclear Medicine (SNM) have planned a joint session on Molecular Imaging and Cancer Therapy: Focus on Clinical Trials. Molecular imaging has been used in small, investigator-mediated studies to detect and stage cancer, to select patients who will respond to therapy, and to monitor tumor response to therapy. Therefore, it is appropriate to ask to what extent imaging can be useful to and available for incorporation into clinical trial protocols. This session will address several aspects of how molecular imaging can achieve this goal, highlighting the partnerships oncologists can forge with molecular imagers to improve the treatment of patients with cancer in the clinical trial setting. This session will take place this Monday, June 1 from 4:45 PM – 6:00 PM in room W415D (Valencia Room).

For more information on the 2009 ASCO Annual Meeting, visit www.asco.org/annualmeeting.

About ASCO
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter. Patient-oriented cancer information is available at www.cancer.net.